Condensed Consolidated Balance Sheets (Unaudited) - USD ($)	Jun. 30, 2022	Dec. 31, 2021
Current Assets:
Cash and cash equivalents	$ 9,156,635	$ 6,062,173
Prepaid research and development	588,931	9,931
Prepaid expenses and other current assets	194,054	389,501
Total Current Assets	9,939,620	6,461,605
Other Assets:
Fixed Assets, net	54,287	58,149
Intangible assets, net	4,759	5,041
Acquired in-process research and development	455,000	455,000
Right-to-use Asset	220,660	246,209
Goodwill	248,971	248,971
Total Assets	10,923,297	7,474,975
Current Liabilities:
Accounts payable	617,778	286,192
Accrued expenses	1,009,042	2,376,930
Accrued expenses, related party	175,000
Lease liability, current	53,136	49,585
Other current liabilities	11,860	9,683
Total Current Liabilities	1,866,816	2,722,390
Contingent liabilities	892,000	1,014,000
Lease liability, non-current	179,702	207,375
Deferred tax liability	23,399	23,399
Total Liabilities	2,961,917	3,967,164
Commitments and contingencies
Shareholders’ Equity
Preferred Stock, 5,000,000 shares authorized with a par value of $0.001 per share, 0 shares outstanding at June 30, 2022 and December 31, 2021
Common Stock, 50,000,000 shares authorized with a par value of $0.001 per share, 25,853,962 and 20,946,712 shares issued and outstanding at June 30, 2022 and December 31, 2021, respectively	25,854	20,947
Additional paid in capital	65,634,012	54,429,979
Accumulated deficit	(57,698,486)	(50,943,115)
Total Shareholders’ Equity	7,961,380	3,507,811
Total Liabilities and Shareholders’ Equity	$ 10,923,297	$ 7,474,975